Martha Sensel
About Martha Sensel
Martha Sensel serves as the Vice President of Portfolio and Public Affairs at CERo Therapeutics, Inc. since 2021, bringing extensive experience in regulatory writing and leadership from her previous roles at Kite Pharma.
Work at Cero Therapeutics
Martha Sensel serves as the Vice President of Portfolio and Public Affairs at Cero Therapeutics, Inc. since 2021. In this role, she is responsible for overseeing portfolio management and public affairs initiatives. Her tenure at Cero Therapeutics is marked by a focus on advancing the company's strategic objectives within the biopharmaceutical sector. Based in South San Francisco, California, she has contributed to the company's efforts in developing innovative therapies.
Previous Experience at Kite Pharma
Martha Sensel has held several key positions at Kite Pharma. She was the Interim Product Team Lead for five months in 2021, where she managed product development initiatives. Prior to that, she served as Executive Director for eight months from 2020 to 2021, overseeing critical projects. Additionally, she worked as the Director of Regulatory Writing from 2016 to 2018, focusing on regulatory documentation and compliance in Santa Monica, California. Currently, she holds the position of Senior Director of Regulatory Writing since 2018.
Education and Expertise
Martha Sensel has an extensive educational background. She studied Nutritional Biochemistry at Cornell University, where she earned her PhD. She also completed a Postdoctoral Research fellowship at Stony Brook University Health Sciences Center School of Medicine. Furthermore, she achieved a Master of Business Administration (MBA) from the University of California, Los Angeles, where she also completed her Postdoctoral Research. Her academic training supports her strong scientific expertise in cell therapy and regulatory affairs.
Leadership and Management Skills
Martha Sensel possesses advanced leadership training that enhances her abilities in leadership and partnership. She has led scientific writing teams at two different companies, which has strengthened her leadership and people management skills. Her experience includes a comprehensive understanding of the regulatory environment from pre-IND to post-market stages, as well as knowledge of global regulatory requirements related to clinical development.
Therapeutic Expertise and Communication Skills
Martha Sensel has key therapeutic expertise in various areas, including oncology, hematology, rheumatology, gastrointestinal disease, and neuropsychiatry. She demonstrates a strong affinity for a broad, inclusive, and agile approach to program management across different stages, including pre-clinical, clinical, and post-marketing. Additionally, she is adept at communicating with both academic and industry-based investigators, facilitating collaboration and knowledge exchange.